About Us

Cann Pharmaceutical Australia (Cann Pharma) was the first Australian company to obtain a joint venture with a licensed medicinal cannabis company in Israel - Cann Pharmaceutical Ltd of Israel.

In Australia, our executive leadership, management, board of directors and our advisors consist of proven business, academic and medical leaders with extensive history of achievement in the medicinal cannabis sector, clinical research and biotechnology and successful business development and capital market expertise.

Collectively, our breadth of experience ranges from advanced agribusiness technology, biotechnology, healthcare and the pharmaceutical sectors, plus proven entrepreneurial & business development to initial public offerings and capital market expertise in Australia, New Zealand, Hong Kong, London, New York and Israel.

Board of Directors

Dr Braden McGrath
Chief Executive Officer

Braden is CEO responsible for leadership of the business and developing strategies for penetrating new markets. Formerly, Braden was CEO of a medical device startup, and CTO of multi-national defense and security company. Braden is also a visiting Distinguished Professor in the US.

Pinhas Tsruya
Exec. Director

Pino is CEO of Cann Pharmaceutical Ltd and is formerly CEO of Assuta, the largest private hospital chain in Israel with eleven clinics and 2,900 employees that provide medical services to one million of patients per year with a total yearly revenue of US$400 million.

David Hercky
Non-Exec. Director

David is Honorary Consul of the Czech Republic in the State of Israel, a Member of the Supervisory Board of AGEL (since 2006), a Czech company operating a chain of hospitals in the Czech and Slovak Republics. He is chairman of the Israeli-Czech Chamber of Commerce.

Management Team

Dr Braden McGrath
Chief Executive Officer

Braden is CEO responsible for leadership of the business and developing strategies for penetrating new markets. Formerly, Braden was CEO of a medical device startup, and CTO of multi-national defense and security company. Braden is also a visiting Distinguished Professor in the US.

Rachel Jaros
Clinical Research Manager

Rachel is is responsible for leading and managing our clinical research trials, including developing research agendas and pipeline, while maintaining regulatory and compliance requirements. Rachel holds an Honours degree in Clinical Neuroscience.

Shahar Chaim
Chief Argonomy Officer

Chief Argonomist for better Holdings of Israel and is responsible for training Australia’s farm management staff. Shahar has over 14 years of experience plant cultivation management. He holds a MS in Argonomy from the Hebrew University and an MBA from Ben Gurion University.

Cultivation Advisor

Yohai Golan Gild
Cultivation Advisor

Founder of better Holdings of Israel, Yohai is an industry pioneer with over 19 years of experience in the medical cannabis industry working in research, development, industrial production, genetic development and products.